Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Mid Cap
Corona Remedies Ltd.
₹1,777
₹1776.00
₹1864.00
₹1336.60
₹1949.40
Markets Today
Historical Performance
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 353.09 | 342.42 | 361.13 | 346.54 | 297.69 |
| Operating Expense | 291.07 | 259.26 | 282.66 | 276.76 | 228.27 |
| Operating Profit | 62.02 | 83.16 | 78.47 | 69.78 | 69.42 |
| Depreciation | 10.29 | 9.45 | 9.20 | 8.92 | 9.69 |
| Interest | 1.38 | 1.66 | 1.93 | 1.99 | 2.39 |
| Tax | 9.41 | 13.94 | 17.46 | 14.49 | 13.33 |
| Net Profit | 45.05 | 41.25 | 52.15 | 46.40 | 44.77 |
₹1777.00
↗ Bullish Moving Average
13
↘ Bearish Moving Average
0
| Held By | Dec 2025 | Mar 2026 |
|---|---|---|
| Promoter | 69 | 69 |
| FII | 1.8 | 2.2 |
| DII | 6.8 | 7.1 |
| Public | 22.4 | 21.8 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 17.12 K | 34.74 K | 49.27% |
| Week | 44.77 K | 1.18 L | 37.89% |
| 1 Month | 23.93 K | 58.02 K | 41.24% |
| 6 Month | 73.89 K | 2.27 L | 32.52% |
Benjamin Graham Value Screen
Consistent high performing stocks over Five Years
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over 1 Year
Expensive Performers (DVM)
Annual Profit Growth higher than Sector Profit Growth
Stocks gaining versus previous close, open price and RSI
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Growth in Net Profit with increasing Profit Margin (QoQ)
Companies with Low Debt
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Near 52 Week High
Negative to Positive growth in Sales and Profit with Strong Price momentum
RSI indicating price strength
Stocks near 52 Week High with Significant Volumes
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 19 Jun, 2026 | 10 | FINAL | 19 Jun, 2026 | Equity Share |
Financials | |||||
|---|---|---|---|---|---|
| Price (₹) | ₹647 | ₹981 | ₹1,057 | ₹4,795 | ₹519.80 |
| % Change | -0.35% | -1.64% | -6.42% | -0.00% | 0.01% |
| Revenue TTM (₹ Cr) | - | ₹1,598.19 | ₹649.50 | ₹935 | ₹4,359.02 |
| Net Profit TTM (₹ Cr) | - | ₹206.20 | ₹115.38 | ₹257.90 | ₹255.19 |
| PE TTM | - | 78.80 | 42.20 | 42.80 | 32.10 |
| 1 Year Return | 9.41 | 102.98 | 112.97 | -4.3 | -4.87 |
| ROCE | 34.78 | 34.76 | 15.60 | - | 11.40 |
Innova Captab Ltd.
₹ 875.00
-0.24%
Blue Jet Healthcare Ltd
₹ 435.25
+3.37%
Concord Biotech Ltd.
₹ 1144.00
+1.67%
Aarti Pharmalabs Ltd.
₹ 707.10
+0.83%
Supriya Lifescience Ltd.
₹ 720.90
+5.39%
Alivus Life Sciences Ltd.
₹ 1062.00
+0.63%
Cohance Lifesciences Ltd.
₹ 428.00
-0.01%
Eris Lifesciences Ltd.
₹ 1352.00
+0.84%
Syngene International Ltd.
₹ 470.40
+0.88%
Alembic Pharmaceuticals Ltd.
₹ 753.10
+3.96%
Sun Pharma Advanced Research Company Ltd.
₹ 179.90
+10.89%
Strides Pharma Science Ltd.
₹ 1146.00
-0.47%
Granules India Ltd.
₹ 766.30
+4.76%
FDC Ltd.
₹ 364.00
+0.58%
Shilpa Medicare Ltd.
₹ 474.00
-0.46%
Jubilant Pharmova Ltd.
₹ 1012.85
+0.31%
Caplin Point Laboratories Ltd.
₹ 2040.00
+2.71%
Marksans Pharma Ltd.
₹ 217.15
-0.22%
Sanofi India Ltd.
₹ 3228.10
+0.98%
Procter & Gamble Health Ltd.
₹ 5335.00
+1.52%
Jeena Sikho Lifecare Ltd.
₹ 655.00
+3.74%
By signing up I certify terms, conditions & privacy policy